Loading stock data…
Decoy Therapeutics Inc. (DCOY)
$9.59+4.07 (+73.79%)
After Hours$8.20-1.39 (-14.49%)· Last close Jun 29
Decoy Therapeutics Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Decoy Therapeutics Inc. in the Healthcare sector is trading at $9.59 with a market capitalization of $3M. Wall Street consensus targets $30.00 (1 analysts), implying a +212.8% move over the next 12 months. The stock is currently near its 52-week low of $4.32, remaining 42.3% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 74 is overbought against a weak tape. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +212.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Overbought RSI 74 against a weak tape — risk of pullback
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$2.28M↑ | -$9.03M↓ | -$895,130↑ | -$965,565↑ | -$1.72M |
| Net Income | -$2.22M↑ | -$8.98M↓ | -$873,467↑ | -$957,825↑ | -$1.71M |
Peer Comparison
JNJUNHPFE
Fundamentals
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverage...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.48M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
0.06
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-336.14%
Volume
Today's trading volume
12.66M
